(University of California - Berkeley) Telomerase, because of its role in cancer and aging, has long been a target of drug companies who want to block it to stop the uncontrolled cell growth characteristic of cancer, or boost it to create a fountain of youth. The structure of the enzyme complex has been a mystery, however, until now. UC Berkeley scientists have finally obtained a detailed picture of the architecture of the RNA-protein complex, a breakthrough for drug design.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2HrDVVG
No comments:
Post a Comment